ZNF57
Zinc finger protein 57
Also known as: ZNF424, ZNF57_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q68EA5
- Gene
- ZNF57
- Ensembl
- ENSG00000171970
- Chromosome
- 19
- Canonical length
- 555 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoli
OverviewNCBI Gene
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
555 residues, UniProt reviewed canonical sequence.
>Q68EA5|ZNF57
1 MDSVVFEDVA VDFTLEEWAL LDSAQRDLYR DVMLETFRNL ASVDDGTQFK ANGSVSLQDM
61 YGQEKSKEQT IPNFTGNNSC AYTLEKNCEG YGTEDHHKNL RNHMVDRFCT HNEGNQYGEA
121 IHQMPDLTLH KKVSAGEKPY ECTKCRTVFT HLSSLKRHVK SHCGRKAPPG EECKQACICP
181 SHLHSHGRTD TEEKPYKCQA CGQTFQHPRY LSHHVKTHTA EKTYKCEQCR MAFNGFASFT
241 RHVRTHTKDR PYKCQECGRA FIYPSTFQRH MTTHTGEKPY KCQHCGKAFT YPQAFQRHEK
301 THTGEKPYEC KQCGKTFSWS ETLRVHMRIH TGDKLYKCEH CGKAFTSSRS FQGHLRTHTG
361 EKPYECKQCG KAFTWSSTFR EHVRIHTQEQ LYKCEQCGKA FTSSRSFRGH LRTHTGEKPY
421 ECKQCGKTFT WSSTFREHVR IHTQEQLHKC EHCGKAFTSS RAFQGHLRMH TGEKPYECKQ
481 CGKTFTWSST LHNHVRMHTG EKPHKCKQCG MSFKWHSSFR NHLRMHTGQK SHECQSYSKA
541 FSCQVILSKT SESTHLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ZNF57 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.47
- Highest tissue expression
- 25 nTPM
Expression across tissuesHPA
Tissue
- testis: 25 nTPM
- skin: 17 nTPM
- stomach: 11 nTPM
- esophagus: 8.7 nTPM
- rectum: 8.7 nTPM
- colon: 7.7 nTPM
Single-cell type
- oocytes: 138 nCPM
- early spermatids: 88 nCPM
- late spermatids: 83 nCPM
- late primary spermatocytes: 51 nCPM
- suprabasal keratinocytes: 35 nCPM
- esophageal apical cells: 34 nCPM
Immune cell
- naive CD4 T-cell: 5.5 nTPM
- T-reg: 5.5 nTPM
- NK-cell: 5.1 nTPM
- memory CD4 T-cell: 4.8 nTPM
- naive CD8 T-cell: 4.8 nTPM
- memory CD8 T-cell: 4.5 nTPM
Brain region
- cerebellum: 20 nTPM
- cerebral cortex: 7.6 nTPM
- pons: 6.8 nTPM
- hippocampal formation: 6.7 nTPM
- thalamus: 6.7 nTPM
- white matter: 6.5 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.53
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.81
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- DNA-binding transcription factor activity, RNA polymerase II-specific
- RNA polymerase II transcription regulatory region sequence-specific DNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ZNF57 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ZNF57 as an antibody target. Whether an autoantibody or antibody against ZNF57 could matter depends on whether native ZNF57 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ZNF57 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ZNF57 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...